Lisa Schulz
Impact in
-
- Liver Diseases and Immunity
- Liver Disease and Transplantation
-
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Liver Disease Diagnosis and Treatment 5
-
- Liver Diseases and Immunity 4
- Liver Disease and Transplantation 1
- Co-authors
- Ansgar W. Lohse (6 shared papers)Marcial Sebode (5 shared papers)Sören Weidemann (2 shared papers)Christoph Schramm (3 shared papers)Roman Zenouzi (2 shared papers)Christina Weiler‐Normann (2 shared papers)Timur Liwinski (1 shared paper)Thorsten Röder (4 shared papers)
In The Last Decade
Lisa Schulz
11 papers receiving 113 citations
Peers
Comparison fields: 5 of 45
- Hepatology 41
- Pharmacology 38
- Epidemiology 35
- Health Informatics 1
- Oncology 11
Countries citing papers authored by Lisa Schulz
This map shows the geographic impact of Lisa Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Schulz more than expected).
Fields of papers citing papers by Lisa Schulz
This network shows the impact of papers produced by Lisa Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Schulz. The network helps show where Lisa Schulz may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Schulz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 39 | |
| 2 | 2020 | 24 | |
| 3 | 2019 | 11 | |
| 4 | 2022 | 9 | |
| 5 | 2018 | 7 | |
| 6 | 2018 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 1981 | 6 | |
| 9 | 2023 | 5 | |
| 10 | 2018 | 3 | |
| 11 | 2021 | 3 | |
| 12 | 2025 | 0 | |
| 13 | 2024 | 0 |
About Lisa Schulz
Lisa Schulz is a scholar working on Epidemiology, Hepatology, Biomedical Engineering, Surgery and Pharmacology, having authored 13 papers that have together received 120 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Liver Diseases and Immunity (4 papers), Innovative Microfluidic and Catalytic Techniques Innovation (4 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Microfluidic and Capillary Electrophoresis Applications (2 papers), Catalytic Processes in Materials Science (1 paper) and Liver Disease and Transplantation (1 paper). The work is most often cited by research in Hepatology (41 citations), Pharmacology (38 citations), Epidemiology (35 citations), Health Informatics (1 citation) and Oncology (11 citations). Lisa Schulz has collaborated with scholars based in Germany, Norway and Libya. Frequent co-authors include Ansgar W. Lohse, Marcial Sebode, Sören Weidemann, Christoph Schramm, Roman Zenouzi, Christina Weiler‐Normann, Timur Liwinski, Thorsten Röder, Rolf Jorde and Johannes Hartl. Their work appears in journals such as Journal of Flow Chemistry, British Journal of Clinical Pharmacology, Scandinavian Journal of Gastroenterology, Regulatory Peptides and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.